Mary Schapiro - Morgan Stanley Independent Director
MS Stock | USD 93.76 1.67 1.81% |
Director
Ms. Mary L. Schapiro is appointed as Independent Director of the company effective July 1, 2018. She is Vice Chair of Promontory Advisory Board, part of Promontory Financial Group. Prior to this, she served as the first Chairwoman of the U.S. Securities and Exchange Commission. Professional Experience Vice Chair for Global Public Policy and Special Advisor to the Founder and Chairman of Bloomberg L.P. since October 2018. Vice Chair of the Advisory Board of Promontory Financial Group LLC, a leading strategy, risk management and regulatory compliance firm, from January 2014 to October 2018. Managing director of Promontory from March 2013 to January 2014. Chair of the Securities and Exchange Commission from January 2009 to December 2012. Chair and CEO of the Financial Industry Regulatory Authority from 2006 to 2008, and served in numerous other key executive positions at FINRA and its predecessor from 1996 to 2006, including Vice Chair and President of NASD Regulation. Chair of the Commodity Futures Trading Commission from 1994 to 1996. Other U.S. Listed Public Company Boards CVS Health Corporation Other U.S. Listed Public Company Boards in the Past Five Years General Electric Company. since 2018.
Age | 65 |
Tenure | 6 years |
Address | 1585 Broadway, New York, NY, United States, 10036 |
Phone | 212 761 4000 |
Web | https://www.morganstanley.com |
Morgan Stanley Management Efficiency
At this time, Morgan Stanley's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.01 in 2024, whereas Return On Capital Employed is likely to drop 0.01 in 2024. At this time, Morgan Stanley's Other Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 719.5 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 22.6 B in 2024. Morgan Stanley's management efficiency ratios could be used to measure how well Morgan Stanley manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Thomas Baltimore | American Express | 57 | |
Mark Chancy | Wells Fargo | 56 | |
John Brennan | American Express | 66 | |
Karen Parkhill | American Express | 55 | |
Eugene McQuade | Citigroup | 69 | |
Diana Taylor | Citigroup | 66 | |
William Weldon | JPMorgan Chase Co | 69 | |
Charles Phillips | American Express | 61 | |
Peter Henry | Citigroup | 51 | |
Deborah Wright | Citigroup | 62 | |
Todd Combs | JPMorgan Chase Co | 50 | |
Christopher Young | American Express | 49 | |
Elaine Chao | Wells Fargo | 62 | |
Lloyd Dean | Wells Fargo | 65 | |
Timothy Flynn | JPMorgan Chase Co | 64 | |
John Chen | Wells Fargo | 61 | |
Gary Reiner | Citigroup | 66 | |
Richard Levin | American Express | 69 | |
Theodore Craver | Wells Fargo | 69 | |
Stephen Sanger | Wells Fargo | 69 | |
Lee Raymond | JPMorgan Chase Co | 80 |
Management Performance
Return On Equity | 0.0917 | ||||
Return On Asset | 0.0078 |
Morgan Stanley Leadership Team
Elected by the shareholders, the Morgan Stanley's board of directors comprises two types of representatives: Morgan Stanley inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Morgan. The board's role is to monitor Morgan Stanley's management team and ensure that shareholders' interests are well served. Morgan Stanley's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Morgan Stanley's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Gorman, Chairman of the Board, Chief Executive Officer | ||
Simon Evenson, Managing Director | ||
Ryosuke Tamakoshi, Director | ||
Judith Miscik, Independent Director | ||
Mary Schapiro, Independent Director | ||
Shelley Leibowitz, Independent Director | ||
Hironori Kamezawa, Director | ||
Erskine Bowles, Lead Independent Director | ||
Erika James, Independent Director | ||
Edward Pick, Head - Institutional Securities | ||
Hutham Olayan, Independent Director | ||
Stanislav Liberman, Managing Director | ||
Eric Grossman, Chief Legal Officer, Executive Vice President | ||
Jonathan Pruzan, Chief Financial Officer, Executive Vice President | ||
Mandell Crawley, Chief Human Resource Officer | ||
Marc Sgaraglino, Managing Director | ||
James JD, COO | ||
Patrick Willcutts, Corporate Retirement Director | ||
Jami Miscik, Independent Director | ||
James Boustead, Compliance Legal | ||
Perry Traquina, Independent Director | ||
Alistair Darling, Independent Director | ||
Michael Pizzi, Head Technology | ||
Stephen Popovchak, Managing Director | ||
Sharon Yeshaya, Chief Financial Officer | ||
Daniel Simkowitz, Head of Investment Management | ||
Stephen Luczo, Independent Director | ||
Thomas Glocer, Lead Independent Director | ||
Simon Herrmann, Head Group | ||
Sachin Wagle, CoHead India | ||
Takeshi Ogasawara, Director | ||
Donald Nicolaisen, Independent Director | ||
Michael Wilson, Chief Officer | ||
Dennis Nally, Independent Director | ||
Rayford Wilkins, Independent Director | ||
James Rosenthal, COO, Executive VP and Member of Operating Committee | ||
Nobuyuki Hirano, Director | ||
Sarah CFA, MD Centers | ||
Andrew Saperstein, Head - Wealth Management | ||
Robyn Goldschmid, Managing Director | ||
Robert Herz, Independent Director | ||
James Owens, Independent Director | ||
Robert Rooney, Head of Technology - Operations and Firm Resilience | ||
Colm Kelleher, Executive Vice President and Presidentident - Institutional Securities | ||
Keishi Hotsuki, Executive Vice President, Chief Risk Officer | ||
Laura Tyson, Independent Director | ||
Jeffrey Brodsky, Chief Human Resource Officer, Executive Vice President | ||
Elizabeth Corley, Independent Director | ||
Raja Akram, Deputy Officer | ||
Gregory Fleming, Executive Vice President and Presidentident - Asset Management and Presidentident - Global Wealth Management Group | ||
Klaus Kleinfeld, Independent Director | ||
Clint Gartin, Chairman Banking |
Morgan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Morgan Stanley a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0917 | ||||
Return On Asset | 0.0078 | ||||
Profit Margin | 0.17 % | ||||
Operating Margin | 0.35 % | ||||
Current Valuation | 34.42 B | ||||
Shares Outstanding | 1.63 B | ||||
Shares Owned By Insiders | 23.31 % | ||||
Shares Owned By Institutions | 62.51 % | ||||
Number Of Shares Shorted | 15.13 M | ||||
Price To Earning | 13.51 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Morgan Stanley. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For more information on how to buy Morgan Stock please use our How to Invest in Morgan Stanley guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Morgan Stock analysis
When running Morgan Stanley's price analysis, check to measure Morgan Stanley's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Morgan Stanley is operating at the current time. Most of Morgan Stanley's value examination focuses on studying past and present price action to predict the probability of Morgan Stanley's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Morgan Stanley's price. Additionally, you may evaluate how the addition of Morgan Stanley to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Transaction History View history of all your transactions and understand their impact on performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Morgan Stanley's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Morgan Stanley. If investors know Morgan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Morgan Stanley listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.188 | Dividend Share 3.4 | Earnings Share 5.5 | Revenue Per Share 33.686 | Quarterly Revenue Growth 0.06 |
The market value of Morgan Stanley is measured differently than its book value, which is the value of Morgan that is recorded on the company's balance sheet. Investors also form their own opinion of Morgan Stanley's value that differs from its market value or its book value, called intrinsic value, which is Morgan Stanley's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Morgan Stanley's market value can be influenced by many factors that don't directly affect Morgan Stanley's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Morgan Stanley's value and its price as these two are different measures arrived at by different means. Investors typically determine if Morgan Stanley is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Morgan Stanley's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.